 | |
| Industry | Biotechnology |
|---|---|
| Founded | August 3, 2016 |
| Founder | Gilles Wainrib, Thomas Clozel |
| Headquarters | Paris , France |
Area served | US, France, UK, Switzerland |
| Products | MSIntuit CRC, RlapsRisk BC |
| Services | AI Drug Discovery, AI Drug Development, AI Diagnostics |
Number of employees | 350 (2023) |
| Website | owkin |
Owkin is an AI biotech company [1] that identifies new treatments, optimizes clinical trials and develops diagnostics.[2] Owkin has collaborated with Amgen to demonstrate the ability of AI to improve cardiovascular prediction.[3]
Company history
Owkin was founded in 2016, by Gilles Wainrib, a professor of Artificial Intelligence, and Thomas Clozel, a clinical research doctor and son of Jean-Paul and Martine Clozel founders of Swiss biotech Actelion.[4]
Fund Raising
- October 30, 2016: The company raises a $2.1 million seed round from friends and family and NJF Capital
- January 16, 2018: The company raises a $11 million series A round with new investors Otium Capital, Cathay Innovation; GV[5]
- May 23, 2018: The company raises a $5 million extension series A round with GV
- March 7, 2019: The company raises a $13 million extension series A round with Eight Roads Venture[6]
- May 7, 2020: The company raises a $35 million extension series A round with MACSF, BPI France
- July 1, 2020: The company raises a $18 million extension series A round with Mubadala Capital Ventures
- November 18, 2021: The company raises a $180 million corporate round with Sanofi
- June 8, 2022: The company raises a $50 million series B round with Bristol Myers Squibb
Valuation
Owkin has raised over $255 million and became a ‘unicorn’ [7] – a startup valued at more than $1 billion – in November 2021 through a $180 million investment from French biopharma company Sanofi.
References
- ↑ Alston, Fiona (2023-03-31). "French AI biotech unicorn Owkin has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment". www.tech.eu. Retrieved 2023-11-01.
- ↑ Doctor, Vanessa (2021-11-18). "Sanofi Taps Millions Into AI Platform for Cancer Drug Discovery". Biospace. Retrieved 2023-11-01.
- ↑ "Amgen, Owkin Use AI to Improve Cardiovascular Risk Prediction". Contract Pharma. Retrieved 2021-12-29.
- ↑ "Owkin heads to Basel". Basel Area Business & Innovation. Retrieved 2021-12-29.
- ↑ "OWKIN Closes $11 Million Series A Financing Round". Cathay Capital. Retrieved 2021-12-29.
- ↑ "Owkin - enabling breakthrough medical research". Eight Roads. Retrieved 2021-12-29.
- ↑ Rosemain, Mathieu (2021-11-18). "Drugmaker Sanofi invests $180 mln in French AI startup Owkin". Reuters. Retrieved 2021-12-29.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.